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Urticarial reactions are characterized by dermal
capillary dilatation and edema, associated with a
variably intense mixed in¯ammatory in®ltrate
consisting of neutrophils, eosinophils, T-helper lym-
phocytes, and activated macrophages. Mast cell
numbers are moderately increased by a factor of 2.4,
in contrast to mastocytosis where numbers are much
higher (5±48-fold increase). In urticarial vasculitis
there is in addition endothelial damage, leukocyto-
clasia, and ®brin and complement deposition. The
emigration of leukocytes is regulated by vasoactive
and chemotactic mediators released from mast cells,
inducing a sequential upregulation of endothelial
adhesion molecules (P-selectin, E-selectin, ICAM-1,
and VCAM-1), of b2-integrins on leukocytes, and of
cytokines on endothelial, epithelial, and in®ltrating
cells. In nonlesional skin, there is also an increase of
mast cells and an upregulation of endothelial adhe-
sion molecules, probably due to molecules in the
circulation of which P-selectin and TNFa have so far
been demonstrated. Whereas these data provide a
molecular basis for the understanding of variations in
mast cell-dependent pathology, they underline the
fact that they are not diagnostic for different types of
urticaria, except for urticarial vasculitis and masto-
cytosis. Key words: cytokines/mast cell/mastocytosis.
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BASIC HISTOLOGY
As expected from the clinical picture, all urticaria biopsies exhibit
an epidermal and dermal edema. With the exception of delayed
pressure urticaria and angioedema, the dermal edema is located
predominantly in the upper dermis and is associated with dilatation
of lymphatic and less so of vascular capillaries (Haas et al, 1998a). In
urticarial vasculitis, there is in addition marked endothelial swelling
and necrosis (Zuberbier et al, 1997a).
In all urticarial reactions, one also ®nds an in¯ammatory in®ltrate
of variable intensity and composition (Table I). Even in wheals of
short duration, as in dermographic and cholinergic urticaria, a
sparse in®ltrate of neutrophils and eosinophils can be observed
(Haas et al, 1995a, 1998a). Neutrophils are particularly prominent
in acute urticaria, which also encompasses most cases of the so-
called neutrophilic urticaria (Haas et al, 1998a; Toppe et al, 1998).
In delayed pressure urticaria, the predominantly eosinophilic and
less so neutrophilic in®ltrate is located primarily in the deep dermis
(Haas et al, 1998a). A strong neutrophilic in®ltrate, with associated
leukocytoclasia, is a special diagnostic feature of urticarial vasculitis
(Zuberbier et al, 1997a). Lymphocytes (mostly CD4-positive) and
activated macrophages are found particularly in older lesions
(Table II), and increased numbers of mast cells (> 2-fold) have
been demonstrated in lesional as well as in uninvolved skin
(Table I) (Czarnetzki et al, 1985, 1990; Haas et al, 1998a; Sabroe
et al, 1999). The increase of mast cells is, however, far more
impressive in urticaria pigmentosa of adults (mean: 6.6-fold
increase) and children (mean: 35.7-fold increase) (BuÈttner et al,
1999).
IMMUNOHISTOLOGIC FINDINGS
As expected from the histologic observations, adhesion molecules
that allow leukocytes to adhere to endothelial cells and migrate into
tissue, the b2-integrins, are markedly upregulated in tissue sections
of urticaria (Haas et al, 1995b), as are MHC class II molecules (Haas
et al, 1996). As also expected from the increased numbers of
eosinophils in the in®ltrate, the granular proteins of eosinophils are
detectable at increased levels (Table III), with MBP being also
detectable within the tissue, whereas ECP is con®ned to both
resting (EG1) and activated (EG2) eosinophils (Haas et al, 1995a). A
lower expression of EG2 was observed in fresh (< 4 h) compared
with older (> 12 h) wheals and in lesions from chronic urticaria
patients exhibiting anti-FceRIa antibodies (Sabroe et al, 1999). In
urticarial vasculitis, deposits of eosinophil peroxidase and neutro-
phil elastase have recently been described in the tissue (Kano et al,
1998), together with classically present ®brin deposits and
complement components (Zuberbier et al, 1997a).
In accordance with the known effects of rapidly released
histamine, P-selectin has been shown to be promptly upregulated
on endothelial cells, and this molecule can even be shown to be
elevated in the circulation (Zuberbier et al, 1997b; Haas et al,
1998b). TNFa, which is partly preformed in and rapidly released
from mast cells and thereafter measurable in the circulation, will
then upregulate E-selectin on endothelial cells, together with the
help of several other mast cell-derived cytokines (Haas et al, 1998b;
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Zuberbier et al, 1997b; Kano et al, 1998). ICAM-1 and V-CAM-1
are observed thereafter in more persisting wheals, including delayed
pressure urticaria (Barlow et al, 1994; Haas et al, 1998b). A number
of mast cell-derived factors also induce leukocytic in®ltration
directly (PAF, LTB4, IL-8, and several other chemokines) or via
secondary mechanisms (tryptase, TNFa) like complement acti-
vation. Several chemotactic and growth factors for mast cells (SCF,
NGF, IL-8, C3a, C5a, TGFa) can in turn be responsible for the
increase in numbers of these cells (Artuc et al, 1999). Expression of
these molecules provides the molecular basis for the increasing
in®ltrate in persisting wheals.
Interestingly, examination of cytokine expression in wheal
biopsies shows that endothelial cells (and, for TNFa, also
keratinocytes) exhibit a striking reactivity for TNFa, IL-3, and
MIF (Czarnetzki et al, 1989; Hermes et al, 1999). The importance
of endothelial cells in whealing pathology is underlined by the
®nding that these cells are also activated in nonlesional skin of
urticaria patients, as evidenced by expression of adhesion molecules
and cytokines (Table I) (Haas et al, 1998b). This suggests a
``priming'' of normal cutaneous tissue in urticaria.
DIAGNOSTIC CONSEQUENCES
Although these ®ndings provide a more detailed understanding of
the molecular pathomechanisms of whealing reactions in urticaria,
biopsies in urticaria are only meaningful for diagnostic purposes if
urticarial vasculitis is to be ruled out. The deep in®ltrate in delayed
pressure urticaria is also unique, but this disease is better diagnosed
on clinical grounds. In urticaria pigmentosa, a biopsy should,
however, be performed to rule out other diseases with increased
mast cell numbers, as associated leukocytic in®ltrates or prolifer-
ation of other cell types and structures that will help to rule out
secondarily increased mast cell numbers, as seen in diverse tumors
and in¯ammatory reactions (Hartmann and Henz, 2001).
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Table II. Immunoreactivity of different types of urticaria
to macrophage subtypesa
Type of urticaria (N) 27E10 RM3/1 25F9
Acute urticaria (4) 1.25 2.25 1.75
Chronic urticaria (6) 0.83 1.33 1.67
Delayed pressure urticaria (9) 1.89 0.94 1.11
Urticaria pigmentosa (6) 0.17 0.92 1.08
aData are expressed as mean score de®ned on a scale of 0±3 for numbers of posi-
tive cells per high power microscopic ®eld. 27E10 reacts primarily with activated
macrophages, RM3/1 and 25F9 with subpopulations of resting tissue macrophages
(for further details, see Czarnetzki et al, 1990).
Table III. Immunoreactivity for eosinophil granule
proteins in different types of urticariaa
MBP EG1* EG2
Type urticaria (N)
Acute urticaria (10) 2.4 22.0 23.0
Chronic urticaria (12) 2.2 22.0 23.1
Delayed pressure urticaria (5) 2.4 28.0 36.0
Cholinergic urticaria (5) 0.6 8.0 13.0
Urticaria pigmentosa (4) 0.0 0.0 3.0
aMajor basic protein (MBP) reactivity is expressed as mean of a score from 0 to
3 for intensity of staining, eosinophil cationic proteins (ECP) as percent positive
cells; *antibody EG1 detects resting and EG2 activated eosinophils (for details, see
Haas et al, 1995a).
Table I. Histologic and immunhistologic ®ndings in
lesional and nonlesional skin of urticariaa
Lesional
skin
Nonlesional
skin
Leukocytic in®ltrate (> 5 cells per 1.41 mm2)§
Neutrophils (% pos. specimens) 25±50* 0.0
Eosinophils (% pos. specimens) 37±75* 0.0
Lymphocytes/monocytes (% pos. specimens) 59±70* 0±20
Mast cells (toluidine blue stain,
cells per §)
10.61 11.14
Endothelial immunoreactivity
E-selectin + +
ICAM-1 + +
P-Selectin + +
E-Selectin + +
MHC II + (+)
IL-3 + +
TNFa + +
MIF + ±
Leukocyte immunoreactivity
b2 ±integrins + ±
IL-3 + ±
TNFa + (+)**
aData are expressed as percentage positive sections, mean cell numbers of mast
cells, or positive versus negative ®ndings (for details, see Haas et al, 1995a,b, 1996,
1998a,b; Zuberbier et al, 1997b). *Findings in neutrophilic urticaria; **only in
delayed pressure urticaria; ±, negative; +, positive; (+), less marked; §, ®ve high
power microscopic ®elds.
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